INS and Stroke: The recent Stroke Hyperglycemia Insulin Network Effort (SHINE) trial, performed in AIS patients with concomitant hyperglycemia, evaluated the impact of intensive versus standard insulin therapy during the first 72 h from symptom onset on a 90-day functional outcome [5].